IFC Catalyzes Breakthrough in Africa’s Vaccine Manufacturing: Biovac Launches Cholera Vaccine Trials
Biovac, an IFC client, has begun clinical trials for South Africa’s first domestically developed oral cholera vaccine—a landmark achievement for Africa’s health security. This innovation promises faster, more reliable access to vaccines...
